- Home
- NERV vs BPT Comparison
NERV vs BPT Comparison
Compare NERV & BPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NERV
- BPT
- Stock Information
- Founded
- NERV 2007
- BPT 1989
- Country
- NERV United States
- BPT United States
- Employees
- NERV N/A
- BPT N/A
- Industry
- NERV Biotechnology: Pharmaceutical Preparations
- BPT Integrated oil Companies
- Sector
- NERV Health Care
- BPT Energy
- Exchange
- NERV Nasdaq
- BPT Nasdaq
- Market Cap
- NERV 10.3M
- BPT 11.7M
- IPO Year
- NERV 2014
- BPT N/A
- Fundamental
- Price
- NERV $1.78
- BPT $0.53
- Analyst Decision
- NERV Hold
- BPT
- Analyst Count
- NERV 1
- BPT 0
- Target Price
- NERV $5.00
- BPT N/A
- AVG Volume (30 Days)
- NERV 18.1K
- BPT 134.0K
- Earning Date
- NERV 05-05-2025
- BPT 05-08-2025
- Dividend Yield
- NERV N/A
- BPT N/A
- EPS Growth
- NERV N/A
- BPT N/A
- EPS
- NERV 0.19
- BPT N/A
- Revenue
- NERV N/A
- BPT $236,000.00
- Revenue This Year
- NERV N/A
- BPT N/A
- Revenue Next Year
- NERV N/A
- BPT N/A
- P/E Ratio
- NERV $9.00
- BPT N/A
- Revenue Growth
- NERV N/A
- BPT N/A
- 52 Week Low
- NERV $1.15
- BPT $0.40
- 52 Week High
- NERV $3.69
- BPT $2.61
- Technical
- Relative Strength Index (RSI)
- NERV 59.64
- BPT 42.71
- Support Level
- NERV $1.52
- BPT $0.51
- Resistance Level
- NERV $1.81
- BPT $0.57
- Average True Range (ATR)
- NERV 0.17
- BPT 0.04
- MACD
- NERV 0.04
- BPT -0.00
- Stochastic Oscillator
- NERV 95.45
- BPT 18.44
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
About BPT BP Prudhoe Bay Royalty Trust
BP Prudhoe Bay Royalty Trust is a grantor trust operating in the US. The property of the Trust consists of an overriding royalty interest. The Royalty Interest entitles the Trust to receive the royalty from the production of crude oil and condensate from the working interest of BP Exploration (Alaska) Inc. in the Prudhoe Bay oil field located on the North Slope of Alaska.